![](/img/cover-not-exists.png)
Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a/NCX1 pathway
Akhtar, Md. Sayeed, Pillai, Krishna Kolappa, Hassan, Md. Quamrul, Dhyani, Neha, Ismail, Md. Vasim, Najmi, Abul KalamLanguage:
english
Journal:
Life Sciences
DOI:
10.1016/j.lfs.2016.03.049
Date:
April, 2016
File:
PDF, 1.18 MB
english, 2016